Larvol Delta - 23andMe-Therapeutics-Announces-Phase-2-Results-for-Two-Additional-Cancer-Cohorts-and-Correlative-Biomarker-Data-from-23ME00610-Study

23ME-00610 - 23andMe

https://www.globenewswire.com/news-release/2024/09/15/2946279/0/en/23andMe-Therapeutics-Announces-Phase-2-Results-for-Two-Additional-Cancer-Cohorts-and-Correlative-Biomarker-Data-from-23ME-00610-Study.html

Sep 15, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next